0

Liver Disease Collection
 41-60 of 966 Articles
Reviews |  1 April 2008 FREE
Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy
Rohit Loomba, MBBS, MHSc; Ayana Rowley, PharmD; Robert Wesley, PhD; et al.
Ann Intern Med. 2008;148(7):519-528. doi:10.7326/0003-4819-148-7-200804010-00008
Articles |  4 March 2008
Brief Communication: Clinical Implications of Short-Term Variability in Liver Function Test Results
Mariana Lazo, MD, ScM; Elizabeth Selvin, PhD, MPH; Jeanne M. Clark, MD, MPH
Ann Intern Med. 2008;148(5):348-352. doi:10.7326/0003-4819-148-5-200803040-00005
Articles |  4 December 2007 FREE
Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis with Telbivudine or Adefovir: A Randomized Trial
Henry L.Y. Chan, MD; E. Jenny Heathcote, MD; Patrick Marcellin, MD; et al.
Ann Intern Med. 2007;147(11):745-754. doi:10.7326/0003-4819-147-11-200712040-00183
Editorials |  4 December 2007 FREE
Evolution of Therapy for Chronic Hepatitis B: Progressing from the Simple to the Complex
Jordan J. Feld, MD; Marc G. Ghany, MD
Ann Intern Med. 2007;147(11):806-808. doi:10.7326/0003-4819-147-11-200712040-00014
Articles |  20 November 2007
Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis
Bart J. Veldt, MD; E. Jenny Heathcote, MD; Heiner Wedemeyer, MD; et al.
Ann Intern Med. 2007;147(10):677-684. doi:10.7326/0003-4819-147-10-200711200-00003
Ideas and Opinions |  3 July 2007
The Natural History and Treatment of Chronic Hepatitis B: A Critical Evaluation of Standard Treatment Criteria and End Points
Ching-Lung Lai, MD; Man-Fung Yuen, MD, PhD
Ann Intern Med. 2007;147(1):58-61. doi:10.7326/0003-4819-147-1-200707030-00010
Articles |  15 May 2007
Differences in Access to Liver Transplantation: Disease Severity, Waiting Time, and Transplantation Center Volume
Jawad Ahmad, MD; Cindy L. Bryce, PhD; Thomas Cacciarelli, MD; et al.
Ann Intern Med. 2007;146(10):707-713. doi:10.7326/0003-4819-146-10-200705150-00004
Articles |  1 May 2007
Antibody to Hepatitis B Core Antigen and Risk for Hepatitis C–Related Hepatocellular Carcinoma: A Prospective Study
Kazuki Ikeda, MD; Hiroyuki Marusawa, MD, PhD; Yukio Osaki, MD; et al.
Ann Intern Med. 2007;146(9):649-656. doi:10.7326/0003-4819-146-9-200705010-00008
Medicine and Public Policy |  16 May 2006
A Framework for Management of Hepatitis C in Prisons
Anne C. Spaulding, MD, MPH; Cindy M. Weinbaum, MD, MPH; Daryl T.-Y. Lau, MD, MPH; et al.
Ann Intern Med. 2006;144(10):762-769. doi:10.7326/0003-4819-144-10-200605160-00010
Editorials |  16 May 2006
Hepatitis C: A Bitter Harvest
Jules L. Dienstag, MD
Ann Intern Med. 2006;144(10):770-771. doi:10.7326/0003-4819-144-10-200605160-00011
Articles |  21 March 2006 FREE
Brief Communication: Severe Hepatotoxicity of Telithromycin: Three Case Reports and Literature Review
Kimberly D. Clay, MD, MPH; John S. Hanson, MD; Scott D. Pope, PharmD; et al.
Ann Intern Med. 2006;144(6):415-420. doi:10.7326/0003-4819-144-6-200503210-00121
Editorials |  21 March 2006
Telithromycin
Michelle Turner, PharmD; G. Ralph Corey, MD; Elias Abrutyn, MD
Ann Intern Med. 2006;144(6):447-448. doi:10.7326/0003-4819-144-6-200603210-00014
Articles |  21 February 2006
Zoledronic Acid Prevents Bone Loss after Liver Transplantation: A Randomized, Double-Blind, Placebo-Controlled Trial
Bronwyn A.L. Crawford, MBBS, PhD; Cherie Kam, MPH, GDipScMed; Julie Pavlovic, RN; et al.
Ann Intern Med. 2006;144(4):239-248. doi:10.7326/0003-4819-144-4-200602210-00005
Articles |  17 January 2006
Brief Communication: Tamoxifen Therapy for Nonmalignant Retroperitoneal Fibrosis
Eric F.H. van Bommel, MD, PhD; Tadek R. Hendriksz, MD; Antonius W.L.C. Huiskes, MD; et al.
Ann Intern Med. 2006;144(2):101-106. doi:10.7326/0003-4819-144-2-200601170-00007
Articles |  15 November 2005
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Masahide Hamaguchi, MD; Takao Kojima, MD; Noriyuki Takeda, MD; et al.
Ann Intern Med. 2005;143(10):722-728. doi:10.7326/0003-4819-143-10-200511150-00009
Editorials |  15 November 2005
Dangerous Liaisons: The Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Elizabeth E. Powell, MBBS, PhD; Julie R. Jonsson, BSc, PhD; Andrew D. Clouston, MBBS, PhD
Ann Intern Med. 2005;143(10):753-754. doi:10.7326/0003-4819-143-10-200511150-00015
Current Clinical Issues |  21 June 2005
Liver Cancer on the Rise
Jennifer Fisher Wilson
Ann Intern Med. 2005;142(12_Part_1):1029-1032. doi:10.7326/0003-4819-142-12_Part_1-200506210-00024
Articles |  17 May 2005
Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis
Fasiha Kanwal, MD, MSHS; Ian M. Gralnek, MD, MSHS; Paul Martin, MD; et al.
Ann Intern Med. 2005;142(10):821-831. doi:10.7326/0003-4819-142-10-200505170-00007
Reviews |  15 March 2005
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
Karl E. Anderson, MD; Joseph R. Bloomer, MD; Herbert L. Bonkovsky, MD; et al.
Ann Intern Med. 2005;142(6):439-450. doi:10.7326/0003-4819-142-6-200503150-00010
Articles |  15 February 2005
A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone
Henry Lik-Yuen Chan, MD; Nancy Wai-Yee Leung, MD; Alex Yui Hui, MB, BChir; et al.
Ann Intern Med. 2005;142(4):240-250. doi:10.7326/0003-4819-142-4-200502150-00006
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)